Search

Your search keyword '"Bronzwaer JG"' showing total 63 results

Search Constraints

Start Over You searched for: Author "Bronzwaer JG" Remove constraint Author: "Bronzwaer JG"
63 results on '"Bronzwaer JG"'

Search Results

Catalog

Books, media, physical & digital resources

3. Doppler-derived intracoronary physiology indices predict the occurrence of microvascular injury and microvascular perfusion deficits after angiographically successful primary percutaneous coronary intervention.

4. Prediction of long-term outcome of cardiac resynchronization therapy by acute pressure-volume loop measurements.

5. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

6. Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).

7. Effects of QRS duration and pacing location on pressure-volume loop evaluation of cardiac resynchronization therapy in end-stage heart failure.

8. Implementation of a prehospital triage system for patients with chest pain and logistics for primary percutaneous coronary intervention in the region of Amsterdam, the Netherlands.

9. Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center.

10. Diastolic and systolic heart failure: different stages or distinct phenotypes of the heart failure syndrome?

11. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.

12. Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction.

13. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.

14. Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillator implantation.

15. Nitric oxide: the missing lusitrope in failing myocardium.

16. Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension.

17. Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.

19. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study.

20. Right coronary artery flow impairment in patients with pulmonary hypertension.

21. The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study.

22. Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects.

23. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.

24. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

25. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension.

26. Myocardial structure and function differ in systolic and diastolic heart failure.

27. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension.

28. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium.

29. Dutch guidelines for interventional cardiology: institutional and operator competence and requirements for training.

30. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension.

31. Cardiomyocyte stiffness in diastolic heart failure.

32. Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction?

33. Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

34. A review of pulmonary arterial hypertension: Part 2: Current and expected treatments.

35. Nitric oxide's role in the heart: control of beating or breathing?

36. What mechanisms underlie diastolic dysfunction in heart failure?

37. A review of pulmonary arterial hypertension: Part 1. Novel insights and classification.

38. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension.

39. [Diagnosis of pulmonary hypertension: experiences with 187 patients referred to the VU Medical Center].

40. [Diastolic heart failure].

41. Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy.

42. Assessment of coronary artery bypass graft disease using cardiovascular magnetic resonance determination of flow reserve.

43. Myocardial contractile effects of nitric oxide.

44. Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart.

45. Epoprostenol-induced pulmonary vasodilatation in patients with pulmonary hypertension measured by electrical impedance tomography.

46. Determination of stroke volume by means of electrical impedance tomography.

47. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion.

48. Diastolic dysfunction in coronary artery disease.

49. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.

50. The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function.